NYSE$MAX

MediaAlpha Inc · Q2 2025 earnings

Q2 2025 earnings · · After market close · Investor relations

Briefing

MediaAlpha Inc reported Q2 2025 results showing strong revenue growth driven by P&C insurance vertical.

Revenue reached $251.6 million, up 41% year-over-year, primarily from increased customer acquisition spending by P&C carriers. The company recorded a net loss of $22.5 million due to a $33 million reserve increase related to the FTC Matter. Adjusted EBITDA rose 31% to $24.5 million.

  • Q2 revenue of $251.6 million increased 41% YoY, led by P&C insurance growth of 69%.
  • Transaction Value hit $480.8 million, up 49% YoY, reflecting higher carrier spending.
  • Net loss of $22.5 million included a $33 million FTC Matter reserve charge.
  • Adjusted EBITDA grew 31% to $24.5 million with Contribution Margin at 15.8%.

Headline financials

Total Revenue

$252M

Previous: $178M+41.1%
EPS (adj)

-$0.33

Previous: $0.07-571.4%
Transaction Value

$481M

Previous: $322M+49.4%
Contribution

$39.8M

No prior period
Contribution Margin

15.8%

Previous: 18.9%-16.4%
Adjusted EBITDA

$24.5M

Previous: $18.7M+30.7%
Capital Expenditures

-$232K

Previous: -$130K-78.5%
Net Income

-$18.7M

Previous: $3.62M-617.7%
Operating Income

-$20M

Previous: $6.49M-408.7%
Gross Profit

$37.7M

Previous: $31.7M+18.9%
Cash & Equivalents

$85.4M

Previous: $28.7M+197.9%
Total Assets

$249M

Previous: $198M+25.8%

Revenue & EPS history

MediaAlpha · Revenue · Quarterly

$252M

Q2 2025+41.1%vs Q2 2024
Beat estimate in 12 of 16 quarters(75%)
ActualEstimate

Revenue by segment

MediaAlpha · $252M total across 4 segments · Q2 2025

  • Property & Casualty insurance
    $227M
  • Health insurance
    $18.1M
  • Life insurance
    $5.23M
  • Other
    $1.16M

Forward guidance

P&C momentum expected to continue near-term despite potential tariff impacts; health vertical faces compliance-driven revenue reduction of ~$70 million for full year.

Tailwinds

  • P&C carriers above target margins with robust competition for share.

Headwinds

  • Under-65 health revenue expected to decline significantly due to FTC settlement compliance.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports

Historical avg

+3.4%

Avg return

Earnings day

+1.5%

Avg return

5 days after

+0.5%

Avg return

30 days after

50%

11 / 22 earnings

Positive

+31.8%

Q3 2022

Best reaction

-18.5%

Q4 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q2 2025
Q1 2026-0.1%-11.3%-11.8%
Q4 2025+12.3%+27.9%+23.4%
Q3 2025+10.8%+20.1%+14.7%
Q1 2025+14.2%+18.2%+21.4%
Q4 2024-18.5%-18.6%-11.0%
Q3 2024-12.6%-17.9%-35.5%
Q2 2024+15.0%+12.1%+23.4%
Q1 2024+9.0%+9.3%-12.2%
Q4 2023+22.3%+24.2%+26.0%
Q3 2023-4.6%-15.8%+0.1%
Q2 2023-3.0%-6.2%-13.2%
Q1 2023-2.4%-6.4%+50.7%
Q4 2022+12.3%+4.8%+1.0%
Q3 2022+31.8%+26.4%+2.3%
Q2 2022-15.0%-32.8%-28.9%
Q1 2022-9.6%-22.0%-31.2%
Q4 2021+28.9%+31.6%+39.1%
Q3 2021-1.5%+12.7%-2.1%
Q2 2021-6.6%-19.1%-25.2%
Q1 2021-13.1%-4.2%+3.6%
Q4 2020+3.3%+8.2%-30.3%
Q3 2020+1.8%-7.4%+7.2%
Q2 2020
Q1 2020
Q4 2019
Q3 2019
Q2 2019
Q1 2019
Q2 2018
Q1 2018

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro